Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), Test (In Vitro, Lal, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021

The global pyrogen testing market was valued at USD 610.2 Million in 2016 and poised to grow at a CAGR of 12.2% between 2016 and 2021, to reach USD 1086.3 Million in 2021. Pyrogens are molecular products of microbial origin that induce immunologic reaction in humans or test animals when administered parenterally. Pyrogen testing is used by pharmaceutical, biotechnological companies and medical devices companies to ensure the absence of these toxic molecular products. The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R&D investments in life sciences industry. Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of pyrogen testing market.

In this report, the global pyrogen testing market is segmented based on applications, products, tests, and geographies. The application segments included in the report are pharmaceuticals and biologicals manufacturing, medical devices manufacturing, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products.

The product segments included in the report are kits and reagents, services, and instruments.

The test segments included in the report are in vitro pyrogen test, LAL (Limulus amebocyte lysate) test, and rabbit test. The LAL test is further subsegmented in to chromogenic tests, turbidimetric tests, and gel clot tests.

Based on geography the pyrogen testing market is segmented into North America, Europe, Asia and Rest of the World (RoW). North America is further segmented into the U.S. and Canada; Europe is further segmented into France, Germany, Italy, Spain, the U.K., and the Rest of Europe (RoE); Asia is further segmented into China, Japan, and India, and the Rest of Asia; and the Rest of the World (RoW) is divided into Africa, Pacific and Oceania, and South America, Central America, and the Caribbean.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global pyrogen testing market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates

Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.)  Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).

Target Audience for this Report:

• Pyrogen testing product manufacturers and vendors
• Research associations related to pharmaceutical and biotechnological research
• contract research organizations (CROs)
• Various research and consulting firms
• Healthcare institutions
• Research institutes
• Distributors of pyrogen testing equipment

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the global pyrogen testing market into the following segments and sub-segments:

• Global Pyrogen Testing Market, By Application
  • Pharmaceuticals and Biologicals Manufacturing
  • Medicals Devices Manufacturing
  • Other Applications
• Global Pyrogen Testing Market, By Product
  • Kits and Reagents
  • Services
  • Instruments
• Global Pyrogen Testing Market, by Test
  • LAL Test
    • Chromogenic Test
    • Turbidimetric Test
    • Gel Clot Test
  • In Vitro Pyrogen Test
  • Rabbit Test
• Global Pyrogen Testing Market, by Geography
  • North America
    • Canada
    • U.S.
  • Europe
    • Germany
    • Italy
    • Spain
    • U.K
    • Rest of Europe
  • Asia
    • China
    • Japan
    • India
    • Rest of Asia
  • Rest of the World
    • Africa
    • Pacific and Oceania
    • South America, Central America, and the Caribbean

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

• Further breakdown of the pyrogen testing market into specific countries in the Middle East and Africa, South America, and Pacific and Oceania

Company Information

• Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Pyrogen Testing Market: Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Pyrogen Testing Market: Research Methodology (Page No. - 19)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions

3 Pyrogen Testing Market: Executive Summary (Page No. - 26)

4 Pyrogen Testing Market: Premium Insights (Page No. - 31)
    4.1 Global Pyrogen Testing Market Overview (2016-2021)
    4.2 Life Cycle Analysis, By Region

5 Pyrogen Testing Market: Overview (Page No. - 35)
    5.1 Introduction
           5.1.1 Market Segmentation
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
                    5.2.1.2 Increasing Number of New Drug Launches
                    5.2.1.3 Strong R&D Investments in the Life Sciences Industry
                    5.2.1.4 Increasing Government Support for Pharmaceutical and Biotechnology Industries
                    5.2.1.5 High Incidence and Large Economic Burden of Chronic Diseases
           5.2.2 Restraints
                    5.2.2.1 High Degree of Consolidation to Act as A Major Barrier for New Entrants
           5.2.3 Opportunities
                    5.2.3.1 Increasing Pharmaceutical Outsourcing
                    5.2.3.2 Developing Countries Present Significant Opportunities for the Pyrogen Testing Market
           5.2.4 Trends
                    5.2.4.1 Shift From Animal-Based Testing to in Vitro Testing

6 Pyrogen Testing Market: Industry Insights (Page No. - 44)
    6.1 Introduction
    6.2 Porter’s Five Forces Analysis
           6.2.1 Threat of New Entrants
           6.2.2 Threat of Substitutes
           6.2.3 Bargaining Power of Buyers
           6.2.4 Bargaining Power of Suppliers
           6.2.5 Intensity of Rivalry
    6.3 Strategic Benchmarking
           6.3.1 Expansions
    6.4 Supply Chain Analysis
           6.4.1 Key Influencers

7 Pyrogen Testing Market, By Product (Page No. - 49)
    7.1 Introduction
    7.2 Kits and Reagents
    7.3 Services
    7.4 Instruments

8 Pyrogen Testing Market, By Application (Page No. - 56)
    8.1 Introduction
    8.2 Pharmaceutical and Biological Manufacturing
    8.3 Medical Device Manufacturing
    8.4 Other Applications

9 Pyrogen Testing Market, By Test Type (Page No. - 63)
    9.1 Introduction
    9.2 LAL Tests
           9.2.1 Chromogenic Tests
           9.2.2 Turbidimetric Tests
           9.2.3 Gel Clot Tests
    9.3 In Vitro Tests
    9.4 Rabbit Tests

10 Pyrogen Testing Market, By Region (Page No. - 75)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia (RoA)
     10.5 Rest of the World (RoW)
             10.5.1 South America, Central America, and the Caribbean
             10.5.2 Pacific and Oceania
             10.5.3 Africa

11 Pyrogen Testing Market: Competitive Landscape (Page No. - 131)
     11.1 Overview
     11.2 Strategic Overview
     11.3 Market Share Analysis
     11.4 Competitive Situation and Trends
             11.4.1 Expansions
             11.4.2 Agreements, Collaborations, and Partnerships
             11.4.3 Acquisitions
             11.4.4 New Product Launches

12 Company Profiles (Page No. - 139)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Associates of Cape Cod, Inc.
     12.3 Charles River Laboratories, Inc.
     12.4 Lonza Group
     12.5 Merck Kgaa
     12.6 Ellab A/S
     12.7 Genscript
     12.8 Hyglos GmbH
     12.9 Thermo Fisher Scientific, Inc.
     12.10 Wako Chemicals Usa, Inc.
     12.11 WUXI Pharmatech (Cayman) Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 165)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports

List of Tables (74 Tables)

Table 1 Global Pyrogen Testing Market Summary
Table 2 Rapid Growth in Pharmaceutical and Biotechnology Industries Driving the Growth of the Market
Table 3 High Degree of Consolidation to Restrict Entry of New Players
Table 4 Increasing Pharmaceutical Outsourcing to Offer Significant Growth Opportunities in the Market
Table 5 Shift From Animal-Based Testing to in Vitro Testing
Table 6 Market Developments Between 2011 and July 2016
Table 7 Pyrogen Testing Market Size, By Product, 2014–2021 (USD Million)
Table 8 Pyrogen Testing Kits and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 9 Pyrogen Testing Services Market Size, By Region, 2014–2021 (USD Million)
Table 10 Pyrogen Testing Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 11 Pyrogen Testing Market Size, By Application, 2014–2021 (USD Million)
Table 12 Market Size for Pharmaceutical and Biological Manufacturing, By Region, 2014–2021 (USD Million)
Table 13 Pyrogen Testing Market Size for Medical Device Manufacturing, By Region, 2014–2021 (USD Million)
Table 14 Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 15 Pyrogen Testing Market Size, By Test Type, 2014–2021 (USD Million)
Table 16 Market Size for LAL Tests, By Region, 2014–2021 (USD Million)
Table 17 Pyrogen Testing Market Size for LAL Tests, By Type, 2014–2021 (USD Million)
Table 18 Market Size for Chromogenic Tests, By Region, 2014–2021 (USD Million)
Table 19 Pyrogen Testing Market Size for Turbidimetric Tests, By Region, 2014–2021 (USD Million)
Table 20 Market Size for Gel Clot Tests, By Region, 2014–2021 (USD Million)
Table 21 Pyrogen Testing Market Size for in Vitro Tests, By Region, 2014–2021 (USD Million)
Table 22 Market Size for Rabbit Tests, By Region, 2014–2021 (USD Million)
Table 23 Pyrogen Testing Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 25 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 26 North America: Market Size, By Test, 2014–2021 (USD Million)
Table 27 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 28 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 29 U.S.: Market Size, By Test, 2014–2021 (USD Million)
Table 30 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 31 Canada: Market Size, By Test, 2014–2021 (USD Million)
Table 32 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 33 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 34 Europe: Market Size, By Test, 2014–2021 (USD Million)
Table 35 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 36 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 37 Germany: Market Size, By Test, 2014–2021 (USD Million)
Table 38 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table 39 U.K.: Market Size, By Test, 2014–2021 (USD Million)
Table 40 France: Market Size, By Product, 2014–2021 (USD Million)
Table 41 France: Market Size, By Test, 2014–2021 (USD Million)
Table 42 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table 43 Italy: Market Size, By Test, 2014–2021 (USD Million)
Table 44 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table 45 Spain: Market Size, By Test, 2014–2021 (USD Million)
Table 46 Rest of Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 47 Rest of Europe: Market Size, By Test, 2014–2021 (USD Million)
Table 48 Asia:Market Size, By Country, 2014–2021 (USD Million)
Table 49 Asia: Market Size, By Application, 2014–2021 (USD Million)
Table 50 Asia: Market Size, By Test, 2014–2021 (USD Million)
Table 51 Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 52 China: Market Size, By Product, 2014–2021 (USD Million)
Table 53 China: Market Size, By Test, 2014–2021 (USD Million)
Table 54 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 55 Japan: Market Size, By Test, 2014–2021 (USD Million)
Table 56 India: Market Size, By Product, 2014–2021 (USD Million)
Table 57 India : Market Size, By Test, 2014–2021 (USD Million)
Table 58 Rest of Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 59 Rest of Asia: Market Size, By Test, 2014–2021 (USD Million)
Table 60 Rest of the World: Market Size, By Region, 2014–2021 (USD Million)
Table 61 Rest of the World: Market Size, By Application, 2014–2021 (USD Million)
Table 62 Rest of the World: Market Size, By Test, 2014–2021 (USD Million)
Table 63 Rest of the World: Market Size, By Product, 2014–2021 (USD Million)
Table 64 South America, Central America, and the Caribbean: Market Size, By Product, 2014–2021 (USD Million)
Table 65 South America, Central America, and the Caribbean: Market Size, By Test, 2014–2021 (USD Million)
Table 66 Pacific and Oceania:  Market Size, By Product, 2014–2021 (USD Million)
Table 67 Pacific and Oceania: Market Size, By Test, 2014–2021 (USD Million)
Table 68 Africa: Market Size, By Product, 2014–2021 (USD Million)
Table 69 Africa : Market Size, By Test, 2014–2021 (USD Million)
Table 70 Market Developments Between 2012 and 2016
Table 71 Expansions, 2012–2016
Table 72 Agreements, Collaborations, and Partnerships, 2012–2016
Table 73 Acquisitions, 2012–2016
Table 74 New Product Launches, 2012–2016

List of Figures (95 Figures)

Figure 1 Global Pyrogen Testing Market
Figure 2 Pyrogen Testing Market: Research Design
Figure 3 Pyrogen Testing Market: Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Pyrogen Testing Market: Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Global Pyrogen Testing Market Size, By Test, 2016 vs 2021 (USD Million)
Figure 8 Global Pyrogen Testing Market Size for LAL Tests, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Pyrogen Testing Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 10 Global Pyrogen Testing Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 11 Global Pyrogen Testing Market Size, By Region, 2016 vs 2021 (USD Million)
Figure 12 Growth in the Pharmaceutical & Biotechnology Industries Will Drive the Global Pyrogen Testing Market During the Forecast Period
Figure 13 Kits & Reagents to Form Largest Product Segment in 2016
Figure 14 Asian Market to Grow at the Highest Rate During the Forecast Period
Figure 15 Asian Market for Pyrogen Testing is in the Growth Phase
Figure 16 Pyrogen Testing Market Segmentation
Figure 17 Pyrogen Testing Market: Drivers, Restraints, Opportunities, & Trends
Figure 18 Number of New Pharmaceutical Drugs Launched, 2003–2013
Figure 19 High Capital Investments to Restrict the Entry of New Players
Figure 20 Direct Distribution Strategy Preferred By Prominent Companies
Figure 21 Kits and Reagents to Form the Largest Product Segment in 2016
Figure 22 North America to Dominate the Pyrogen Testing Kits and Reagents Market in 2016
Figure 23 North America to Dominate the Pyrogen Testing Services Market in 2016
Figure 24 North America to Command the Largest Share of Pyrogen Testing Instruments Market in 2016
Figure 25 Pyrogen Testing Market Size, By Application, 2016 (USD Million)
Figure 26 North America to Dominate the Pharmaceutical and Biological Manufacturing Segment in 2016
Figure 27 North America to Dominate the Medical Device Manufacturing Segment in 2016
Figure 28 Asia to Witness Highest Growth in Other Applications Segment During the Forecast Period
Figure 29 Pyrogen Testing Market Size, By Test Type, 2016 (USD Million)
Figure 30 North America to Dominate the LAL Tests Segment in 2016
Figure 31 Pyrogen Testing Market Size for LAL Tests, By Type, 2016 (USD Million)
Figure 32 Asia to Witness Highest Growth in the Chromogenic Tests Segment During the Forecast Period
Figure 33 North America to Dominate the Turbidimetric Tests Segment in 2016
Figure 34 North America to Command the Largest Share of the Gel Clot Tests Segment During the Forecast Period
Figure 35 Asia to Witness Highest Growth in the in Vitro Tests Segment During the Forecast Period
Figure 36 North America to Dominate the Rabbit Tests Segment in 2016
Figure 37 North America to Dominate the Global Pyrogen Testing Market in 2016
Figure 38 Asian Pyrogen Testing Market to Witness the Highest Growth During the Forecast Period (2016-2021)
Figure 39 North America: Pyrogen Testing Market Snapshot
Figure 40 U.S. to Witness Highest Growth in the North American Pyrogen Testing Market During the Forecast Period
Figure 41 Pharmaceutical and Biological Manufacturing to Command the Largest Share of the Market, By Application, in 2016
Figure 42 LAL Tests, the Largest Test Segment of the North American Market
Figure 43 Kits and Reagents to Hold Largest Share of the Market, By Product, in 2016
Figure 44 Kits and Reagents, the Largest Product Segment in the U.S. in 2016
Figure 45 LAL Tests Hold the Largest Share in the U.S. Market, By Test
Figure 46 Kits and Reagents Dominate the Market, By Product
Figure 47 LAL Tests Command the Largest Share in the Canadian Market
Figure 48 Germany to Witness Highest Growth in the European Pyrogen Testing Market During the Forecast Period (2016-2021)
Figure 49 Pharmaceutical and Biologicals Application Segment to Command the Largest Share of the European Pyrogen Testing Market in 2016
Figure 50 LAL Test to Dominate the European Market, By Test, in 2016
Figure 51 Kits and Reagents to Hold the Largest Share of the Pyrogen Testing Product Market in Europe in 2016
Figure 52 Kits and Reagents Hold Largest Share of the Pyrogen Testing Product Market in Germany
Figure 53 LAL Tests to Show the Highest Growth in the German Market, By Test
Figure 54 Kits and Reagents, the Dominant Product Segment in the U.K. Market
Figure 55 LAL Tests Command Largest Share of the U.K. Tests Market in 2016
Figure 56 Kits and Reagents are the Largest and the Fastest-Growing Product Segment in France
Figure 57 LAL Tests, the Largest and the Fastest-Growing Test Segment in France
Figure 58 Kits and Reagents Form the Largest Product Segment in the Italian Market, 2016
Figure 59 LAL Tests to Witness the Highest Growth in the Italian Market, By Test
Figure 60 Kits and Reagents Form the Largest Product Segment in Spain
Figure 61 LAL Tests Segment to Dominate the Spanish Market in 2016
Figure 62 Kits and Reagents Segment to Grow at the Highest Rate in the RoE
Figure 63 LAL Tests Account for the Largest Share of the Pyrogen Testing Market in the Rest of Europe
Figure 64 Asia: Pyrogen Testing Market Snapshot
Figure 65 China to Witness the Highest Growth in the Asian Pyrogen Testing Market in 2016
Figure 66 Pharmaceutical and Biological Manufacturing Application Segment to Command the Largest Share of the Asian Market in 2016
Figure 67 LAL Tests to Dominate the Asian Market in 2016
Figure 68 Kits and Reagents to Hold the Largest Share of the Pyrogen Testing Product Market in Asia in 2016
Figure 69 Kits and Reagents, the Fastest-Growing Product Segment in the Chinese Market
Figure 70 LAL Tests Hold Largest Share of the Chinese Pyrogen Testing Market in 2016
Figure 71 Kits and Reagents, the Largest Product Segment in Japan
Figure 72 LAL Tests Dominate the Japanese Pyrogen Testing Market in 2016
Figure 73 Kits and Reagents, the Largest and Fastest-Growing Product Segment in the Indian Market
Figure 74 LAL Tests Dominate the Indian Market, By Test
Figure 75 Kits and Reagents Command the Largest Share of the RoA Pyrogen Testing Market
Figure 76 LAL Tests to Witness the Highest Growth in the RoA Pyrogen Testing Market
Figure 77 South America, Central America, and Caribbean to Witness Highest Growth in the RoW Pyrogen Testing Market
Figure 78 Pharmaceutical and Biologicals Application Segment to Command the Largest Share of the RoW Pyrogen Testing Market in 2016
Figure 79 LAL Tests to Dominate the RoW Pyrogen Test Market in 2016
Figure 80 Kits and Reagents, the Largest Product Segment in the RoW Market
Figure 81 Kits and Reagents Hold the Largest Share of the Pyrogen Testing Products Market in South America, Central America, and the Caribbean
Figure 82 LAL Tests, the Largest Test Segment in the South America, Central America, and the Caribbean Market
Figure 83 Kits and Reagents to Dominate the Pacific and Oceania Market
Figure 84 LAL Tests to Hold the Largest Share of the Pyrogen Testing Market in 2016
Figure 85 Kits and Reagents Forms the Largest and the Fastest-Growing Product Segment in Africa, 2016
Figure 86 LAL Tests to Grow at the Highest Rate in the African Market
Figure 87 Expansions and Agreements, Collaborations, and Partnerships are the Key Strategies Adopted By Players Between 2012 & 2016
Figure 88 Pyrogen Testing Market Share Analysis, By Key Player, 2015
Figure 89 Financial Performances of Leading Market Players (2013–2015)
Figure 90 Company Snapshot: Charles River Laboratories, Inc.
Figure 91 Company Snapshot: Lonza Group
Figure 92 Company Snapshot: Merck KGAA
Figure 93 Company Snapshot: Genscript
Figure 94 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 95 Company Snapshot: WUXI Pharmatech (Cayman) Inc.

The global pyrogen testing market is valued at USD 610.2 Million in 2016 and is expected to grow at a CAGR of 12.2%, to reach USD 1086.3 Million by 2021.  Pyrogen testing is important and mandatory step in the manufacturing process to remove or inactivate potential bacterial toxins. Pyrogen testing product are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise. Also, many of pharmaceutical and biotechnology firms are gearing to cater to the growing demands of medicines. This aids to the growth of market.

This report segments the global pyrogen testing market into applications, products, tests, and geographies. Based on applications, the global market is segmented into pharmaceuticals and biologicals manufacturing, medical devices manufacturing, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products.

On the basis of product type, the global pyrogen testing market is segmented into  kits and reagents, services, and instruments.

On the basis Test Type, the pyrogen testing market is divided into  in vitro pyrogen test, LAL (Limulus amebocyte lysate) test, and rabbit test. The LAL test is further subsegmented in to chromogenic tests, turbidimetric tests, and gel clot tests.

Based on geography the pyrogen testing market is segmented into North America, Europe, Asia and Rest of the World (RoW). North America is further segmented into the U.S. and Canada; Europe is further segmented into France, Germany, Italy, Spain, the U.K., and the Rest of Europe (RoE); Asia is further segmented into China, Japan, and India, and the Rest of Asia; and the Rest of the World (RoW) is divided into Africa, Pacific and Oceania, and South America, Central America, and the Caribbean.

The high degree of market consolidation is a major factor restraining the growth of pyrogen testing market. The major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.)  Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst